Shanghai Longwood Biopharmaceuticals Co., Ltd.

This study tests an experimental oral medication called LW402 for adults with moderate-to-severe atopic dermatitis (eczema). About 480 participants will receive either the drug or a placebo to see if it safely improves skin symptoms like redness and itching. The main goal is to m…

This study tests an experimental tablet called LW402 in 180 adults with non-segmental vitiligo, a condition causing white patches on the skin. Participants will take one of three doses or a placebo daily for up to 52 weeks. The main goal is to see if the drug helps bring back ski…